D.E. Shaw & Co
QTTB icon

D.E. Shaw & Co’s Q32 Bio QTTB Stock Holding History

D.E. Shaw & Co’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-12,503
Closed -$443K – 5586
2022
Q2 		$443K Buy
12,503
+2,389
+24% +$81.6K ﹤0.01% 4165
2022
Q1 		$554K Buy
10,114
+4,964
+96% +$308K ﹤0.01% 4303
2021
Q4 		$338K Sell
5,150
-8,976
-64% -$871K ﹤0.01% 4627
2021
Q3 		$2M Sell
14,126
-981
-6% -$125K ﹤0.01% 3035
2021
Q2 		$1.98M Buy
15,107
+12,040
+393% +$1.5M ﹤0.01% 2952
2021
Q1 		$519K Buy
3,067
+824
+37% +$174K ﹤0.01% 3483
2020
Q4 		$456K Buy
+2,243
New +$434K ﹤0.01% 3430
2020
Q3 		– Sell
-3,926
Closed -$1.07M – 4228
2020
Q2 		$1.07M Buy
+3,926
New +$1.05M ﹤0.01% 2881

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

D.E. Shaw & Co's QTTB Position: Q3 2022 in Review

D.E. Shaw & Co sold out of Q32 Bio (QTTB) in Q3 2022, closing a stake of 12,503 shares — an estimated $443K sold.

D.E. Shaw & Co first reported a position in QTTB in Q2 2020 and held it in 8 quarters. The position peaked at $2M in Q3 2021. 83 funds tracked by Wall St. Rank hold QTTB as of Q3 2022.

  • D.E. Shaw & Co reported no remaining Q32 Bio position as of Q3 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 12,503 Q32 Bio shares in Q3 2022, an estimated $443K.
  • D.E. Shaw & Co first reported a position in Q32 Bio in Q2 2020 and held it in 8 quarters.
  • D.E. Shaw & Co's Q32 Bio position peaked at $2M in Q3 2021.
  • 83 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.